University of North Carolina Health Care Jun 13 2025 A combination therapy that adds a recently approved drug to the current standard of care for newly diagnosed acute myeloid leukemia (AML) showed high rates of complete remission in an early-phase clinical trial conducted at UNC Lineberger Comprehensive Cancer Center and 11 other sites nationwide. The trial findings will be published in the Journal of Clinical Oncology ( JCO ) and presented at the European Hematology Association Congress in